Clinical Trial Update: Bifidobacterium Animalis Subsp. Lactis in Prevention of Common Infections in Healthy Children Attending Day Care Centers [NA]

View source ↗

Summary

A completed clinical trial evaluated the probiotic Bifidobacterium animalis subsp. lactis for preventing gastrointestinal and respiratory infections in healthy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis
• Respiratory Infection

Drugs mentioned

• BB-12 (Bifidobacterium animalis subsp. lactis) (Bifidobacterium animalis subsp. lactis)

Snippet

Sponsor: Children's Hospital Zagreb | Conditions: Gastrointestinal Tract Infections, Respiratory Tract Infections | NA | Status: COMPLETED